Compare GraniteShares 2x Long COIN Daily ETF (CONL) vs Medpace Holdings Inc (MEDP) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
GraniteShares 2x Long COIN Daily ETF vs Medpace Holdings Inc — how do they compare? GraniteShares 2x Long COIN Daily ETF trades at $4.36, while Medpace Holdings Inc trades at $582 (market cap $16.66B). The key difference: Medpace Holdings Inc is trading nearer its 52-week high, GraniteShares 2x Long COIN Daily ETF nearer its low. Which is the better fit depends on your goals.
| CONL | MEDP | |
|---|---|---|
Sector | Leveraged / Inverse | Technology |
52-Week High | $48.70 | $620.59 |
52-Week Low | $3.93 | $393.42 |
Market Cap | — | $16.66B |
Enterprise Value | — | $16.28B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
CONL (GraniteShares 2x Long COIN Daily ETF) trades at $4.11, up 0.49% with a bearish technical outlook as moving averages signal strong selling pressure. The ETF has experienced significant volatility, declining 67% year-to-date according to 24/7 Wall Street (June 6, 2026), reflecting the inherent risks of daily-reset leveraged strategies. Recent news highlights investor challenges with timing leveraged ETF investments.
The outlook remains challenging due to structural volatility decay in daily-reset leveraged products. While cryptocurrency market trends may provide occasional upside, the compounding effect of daily rebalancing creates substantial headwinds for long-term holders. Risk management is critical given the amplified exposure to Coinbase stock movements.
MEDP trades at $596.98, down 1.41% today but maintains a bullish technical outlook with strong moving average support. The company demonstrates robust fundamentals with 17.2% YoY revenue growth in Q2 2026 and consistent earnings beats, though valuation metrics remain elevated with a P/E of 35.08. Recent news highlights record Q2 bookings and raised 2026 guidance, while technical indicators show the stock trading near pivot point resistance at $598.
MEDP presents a growth opportunity with strong operational performance and positive analyst sentiment, though premium valuation and potential legal scrutiny pose risks. The stock's technical strength and fundamental momentum support further upside toward the $692 price target, but investors should monitor the ongoing legal investigation and valuation compression risks in a volatile market environment.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About GraniteShares 2x Long COIN Daily ETF
CONL is a leveraged ETF that seeks to provide two times (2x) the daily performance of Coinbase Global (COIN) stock. It is designed for investors seeking magnified short-term exposure to the price movements of Coinbase.
Read more on CONL →About Medpace Holdings Inc
Medpace Holdings, Inc. is a full-service clinical contract research organization (CRO) that provides comprehensive and scientifically-driven clinical development services to the biotechnology, pharmaceutical, and medical device industries. The company specializes in conducting global clinical trials for new drug and medical device approvals. Medpace's model emphasizes therapeutic expertise and a highly integrated approach to accelerate the clinical development process for its clients.
Read more on MEDP →
